Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia

Background/Objectives: Oral squamous cell carcinoma often arises from oral leukoplakia, a precancerous lesion. Distinguishing malignant transformation from leukoplakia currently relies on repeated, invasive biopsies. A noninvasive method to discriminate OSCC from leukoplakia is needed. Fatty acid metabolic reprogramming in cancers alters serum free fatty acid (FFA) profiles. We aimed to identify serum FFAs that distinguish OSCC from leukoplakia. Methods: The gene expression of fatty acid metabolizing enzymes in leukoplakia and OSCC tissues was assessed using a public microarray dataset. Serum levels of 21 FFAs were quantified by liquid chromatography–tandem mass spectrometry in 68 healthy donors, 26 patients with leukoplakia, and 38 patients with OSCC. Results: Fatty acid metabolizing enzyme genes were differentially expressed between leukoplakia and OSCC tissues, with upregulation of genes involved in de novo synthesis and downregulation of those involved in fatty acid uptake and lipolysis. Seven serum FFAs were significantly altered in OSCC from the early stage, whereas serum FFA levels in healthy donors were comparable to those in leukoplakia. Three of the altered FFAs—stearic acid, arachidic acid, and lauric acid—each discriminated OSCC from leukoplakia with high accuracy as single markers (area under the curve > 0.9), independently of clinical stage, age, and smoking history. Lauric acid was effective across the full clinical spectrum and the least affected by body composition, making it the most suitable for practical implementation. Conclusions: Serum FFA profiling represents a promising noninvasive strategy for the early detection of OSCC, with the potential to complement biopsy in the surveillance of leukoplakia.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-18
DOI
https://doi.org/10.3390/cancers18223688
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia

Kanako Yamagata, Yuki Katoh, Hisataka Kitano, Mamiko Fukuta et al.
Cancers
Cancer, Lipids, and Metabolism
article

Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia

Kanako Yamagata, Yuki Katoh, Hisataka Kitano, Mamiko Fukuta, Masaki Sugawara, Yuichiro Otsuka, Shuichi Hirai, Tadashi Ogawa, Yosuke Fujii, Ayase Futatsugi, Emily Chang, Anna Nishihara
article en

Abstract

Background/Objectives: Oral squamous cell carcinoma often arises from oral leukoplakia, a precancerous lesion. Distinguishing malignant transformation from leukoplakia currently relies on repeated, invasive biopsies. A noninvasive method to discriminate OSCC from leukoplakia is needed. Fatty acid metabolic reprogramming in cancers alters serum free fatty acid (FFA) profiles. We aimed to identify serum FFAs that distinguish OSCC from leukoplakia. Methods: The gene expression of fatty acid metabolizing enzymes in leukoplakia and OSCC tissues was assessed using a public microarray dataset. Serum levels of 21 FFAs were quantified by liquid chromatography–tandem mass spectrometry in 68 healthy donors, 26 patients with leukoplakia, and 38 patients with OSCC. Results: Fatty acid metabolizing enzyme genes were differentially expressed between leukoplakia and OSCC tissues, with upregulation of genes involved in de novo synthesis and downregulation of those involved in fatty acid uptake and lipolysis. Seven serum FFAs were significantly altered in OSCC from the early stage, whereas serum FFA levels in healthy donors were comparable to those in leukoplakia. Three of the altered FFAs—stearic acid, arachidic acid, and lauric acid—each discriminated OSCC from leukoplakia with high accuracy as single markers (area under the curve > 0.9), independently of clinical stage, age, and smoking history. Lauric acid was effective across the full clinical spectrum and the least affected by body composition, making it the most suitable for practical implementation. Conclusions: Serum FFA profiling represents a promising noninvasive strategy for the early detection of OSCC, with the potential to complement biopsy in the surveillance of leukoplakia.

CancersVol. 18(22)
Nihon University (JP), Aichi Medical University (JP), Keio University (JP), Nihon University Itabashi Hospital (JP)
Ministry of Education, Culture, Sports, Science and Technology
Good health and well-being
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon